Guillin O, Diaz J, Carroll P, Griffon N, Schwartz JC, Sokoloff P (2001) BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization
Induces deep delta sleep
Regular follow-ups with healthcare professionals are essential to monitor any serious reactions and adjust treatment plans as needed, ensuring that patients can safely benefit from this innovative medication
We oversee the entire lyophilization process at our facility
When injected into osteoarthritic joints, exosomes are shown to regenerate cartilage, reduce synovitis, and promote bone remodeling
From REDEFINE-1: Nausea: 55% of CagriSema participants vs 12.6% with placebo Constipation: 30.7% vs 11.6% Vomiting: 26.1% vs 4.1% Discontinuation rate: 5.9% vs 3.5% placebo comparable to Wegovy (6.9%) and Zepbound (6.2%) The nausea rate (55%) is higher than the ~4045% typical for semaglutide alone